We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Virtual Reality Helmet to Test for Problems With Memory (DETECT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00454454
First Posted: March 30, 2007
Last Update Posted: July 30, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Wallace H. Coulter Foundation
Information provided by (Responsible Party):
David Wright, Emory University
March 28, 2007
March 30, 2007
July 30, 2013
March 2007
July 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00454454 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Virtual Reality Helmet to Test for Problems With Memory
Display Enhanced TEsting for Cognitive Impairment and Traumatic Brain Injury
The purpose of this research study is to compare a virtual reality display device with the standard neuropsychological evaluation for detecting mild cognitive impairment (problems with memory, concentration, reaction time, etc.).

Since many individuals with mild cognitive impairment (MCI) appear to function normally, MCI may often be recognizable through testing in advance of any changes noticed by family members or caregivers. Early and frequent testing can therefore trigger an earlier diagnosis, which may increase the effectiveness of currently available medications used to delay onset of Alzheimer's symptoms. Primary care and geriatric physicians currently lack the necessary tools required for quick and accurate MCI screening in the doctor's office environment. The current industry-standard is a battery of pen & paper neuropsychological tests that require 1.5 hours in a quiet room with a neuropsychologist.

Comparison: virtual reality display device compared to the standard neuropsychological evaluation for detecting mild cognitive impairment (problems with memory, concentration, reaction time, etc.).

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
geriatric clinic, retirement facilities
Memory
Not Provided
No treatment
Wright DW, Nevárez H, Kilgo P, LaPlaca M, Robinson A, Fowler S, Brumfield J, Goldstein FC. A novel technology to screen for cognitive impairment in the elderly. Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):484-91. doi: 10.1177/1533317511426133. Epub 2011 Nov 22.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
425
July 2010
July 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 65 yrs of age and older
  • MMSE of 18 or greater or mini-cog of 4 or greater
  • Ability to read
  • Informed consent given

Exclusion Criteria:

  • Visual, hearing or physical impairment that would limit ability to use the virtual reality helmet or control device
  • Non-English speaking
Sexes Eligible for Study: All
65 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00454454
797-2002
No
Not Provided
Not Provided
David Wright, Emory University
Emory University
Wallace H. Coulter Foundation
Principal Investigator: David W Wright, MD Emory University
Emory University
July 2013